MIRA Pharmaceuticals, Inc. Common Stock (MIRA) — Cash Flow-to-Debt Ratio
MIRA Pharmaceuticals, Inc. Common Stock (MIRA) has a Cash Flow-to-Debt Ratio of -13.07x as of September 2025, meaning its operating cash flow of $-1.10 Million could theoretically repay -13% of its total liabilities ($83.93K) in one year. See MIRA Pharmaceuticals, Inc. Common Stock (MIRA) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
MIRA Pharmaceuticals, Inc. Common Stock Cash Flow-to-Debt Ratio (2020–2024)
Historical debt coverage capacity for MIRA Pharmaceuticals, Inc. Common Stock across 5 annual periods. Also explore how fast is MIRA Pharmaceuticals, Inc. Common Stock growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for MIRA Pharmaceuticals, Inc. Common Stock (2020–2024)
Year-by-year debt coverage analysis for MIRA Pharmaceuticals, Inc. Common Stock. For market capitalisation and broader financial context, see market cap of MIRA Pharmaceuticals, Inc. Common Stock.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -7.69x | $-5.56 Million | $723.35K | ▲ +5.3% |
| 2023 | -8.12x | $-4.53 Million | $558.10K | ▼ -110.7% |
| 2022 | -3.85x | $-5.60 Million | $1.45 Million | ▼ -206.3% |
| 2021 | -1.26x | $-1.38 Million | $1.09 Million | ▼ -67.2% |
| 2020 | -0.75x | $-67.99K | $90.36K | — |